L3VLUP
ProSign in

LEGN · JNJ in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

LEGNJNJ
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • LEGN
  • JNJ
0204060202120222023202420252026
Holders and value by quarter
QuarterLEGNJNJ
Q3 20202 holders, $116m30 holders, $26.2bn
Q4 20203 holders, $123m32 holders, $26.6bn
Q1 20214 holders, $170m31 holders, $25.3bn
Q2 20214 holders, $178m37 holders, $25.6bn
Q3 20215 holders, $387m40 holders, $24.1bn
Q4 20216 holders, $401m33 holders, $25.2bn
Q1 20227 holders, $338m35 holders, $28.2bn
Q2 20229 holders, $993m33 holders, $26.9bn
Q3 20228 holders, $847m36 holders, $25.4bn
Q4 20229 holders, $1.1bn35 holders, $27.6bn
Q1 202310 holders, $1.2bn42 holders, $24.5bn
Q2 202311 holders, $2.5bn38 holders, $25.0bn
Q3 202312 holders, $2.4bn37 holders, $18.9bn
Q4 202311 holders, $2.1bn31 holders, $19.0bn
Q1 202410 holders, $2.1bn32 holders, $19.7bn
Q2 20248 holders, $1.6bn35 holders, $20.4bn
Q3 20249 holders, $1.8bn28 holders, $22.3bn
Q4 202410 holders, $523m37 holders, $20.4bn
Q1 20258 holders, $916m32 holders, $20.5bn
Q2 20256 holders, $1.1bn31 holders, $18.4bn
Q3 20255 holders, $1.1bn32 holders, $23.7bn
Q4 20256 holders, $679m29 holders, $27.8bn
Q1 20264 holders, $155m34 holders, $35.6bn
Q2 20265 holders, $1.0bn33 holders, $39.1bn
LEGN

Legend Biotech Corp

Holders
11
Reported value
$2.1bn
Buyers
6
Sellers
5

Breadth +1 among 93 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations
JNJ

Johnson & Johnson

Holders
31
Reported value
$19.0bn
Buyers
16
Sellers
16

Breadth 0 among 93 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q4 2023

Among the 34 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only LEGN (3)

Artisan Partners LP, Capital World Investors, Holocene Advisors LP

Only JNJ (23)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Capital Research Global Investors, Caxton Associates LLP, D. E. Shaw & Co., Dodge & Cox, ExodusPoint Capital Management LP, GAMCO Investors Inc, Invesco Ltd, Jane Street Group LLC, Man Group PLC, Markel Group Inc, Neuberger Berman Group LLC, Quantbot Technologies LP, Renaissance Technologies LLC, Squarepoint Ops LLC, Susquehanna International Group LLP, Tudor Investment Corp, Two Sigma Advisers LP, Two Sigma Investments LP, Verition Fund Management LLC, Voloridge Investment Management LLC

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →